Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial-Reference-Cited by-同舟云学术

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Published:2015-10 Issue:13 Volume:16 Page:1295-1305
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Burnett Alan K,Russell Nigel H,Hills Robert K,Bowen David,Kell Jonathan,Knapper Steve,Morgan Yvonne G,Lok Jennie,Grech Angela,Jones Gail,Khwaja Asim,Friis Lone,McMullin Mary Frances,Hunter Ann,Clark Richard E,Grimwade David

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARa-positive acute promyelocytic leukemia;Sanz;Blood,1999

2. A randomized comparison of alltrans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia;Fenaux;Blood,1999

3. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol;Tallman;Blood,2002

4. Presenting white cell count and kinetics of molecular remission predict prognosis acute promyelocytic leukaemia treated with all-trans retinoic acid: result of the Randomized MRC Trial;Burnett;Blood,1999

5. Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial;Burnett;Leukemia,2013

Cited by 440 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Maximizing arsenic trioxide's anticancer potential: Targeted nanocarriers for solid tumor therapy;Colloids and Surfaces B: Biointerfaces;2024-09

3. Analysis of the occurrence and liver function characteristics of arsenic-associated liver injury during the treatment of pediatric patients with acute promyelocytic leukemia;Annals of Hematology;2024-08-21

4. Chemotherapy-free approaches to newly-diagnosed acute promyelocytic leukaemia: is oral-arsenic trioxide/all-trans retinoic acid/ascorbic acid the answer?;Expert Review of Hematology;2024-08-12

5. Visual Hallucinations With Arsenic Trioxide Therapy in Acute Promyelocytic Leukemia;Cureus;2024-08-12